Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2025

Tan PH, Ellis IO, Allison KH, Badve SS, Brogi E, Callagy G, et al. Malignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteria. Histopathology. 2025.

Britto LS, Balasubramani D, Desai S, Phillips P, Trehan N, Cesarman E, et al. T Cells Spatially Regulate B Cell Receptor Signaling in Lymphomas through H3K9me3 Modifications. Adv Healthc Mater. 2025;14(5):e2401192.

Febres-Aldana CA, Elsayad MM, Saliba M, Bhanot U, Ntiamoah P, Takeyama A, et al. Analysis of ASCL1/NEUROD1/POU2F3/YAP1 Yields Novel Insights for the Diagnosis of Olfactory Neuroblastoma and Identifies Sinonasal Tuft Cell-Like Carcinoma. Mod Pathol. 2025;38(3):100674.

Villa CH, Biondich P, Draper NL, Dores GM, Storch E, Chada K, et al. Patterns of platelet use evaluated in EHR networks of the Biologics Effectiveness and Safety Initiative, 2012-2018. Transfusion. 2025;65(2):267-276.

2024

Manzo OL, Nour J, Sasset L, Marino A, Rubinelli L, Palikhe S, et al. Rewiring Endothelial Sphingolipid Metabolism to Favor S1P Over Ceramide Protects From Coronary Atherosclerosis. Circ Res. 2024.

L Medeiros J, Chadburn A, Natkunam Y, Naresh KN. Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissues: B-cell Neoplasms. Mod Pathol. 2024;37(4):100441.

Fein JA, Patel SS. Under AI's lens: spotting mutations visually. Blood Adv. 2024;8(3):827-828.

Geyer JT. Current Challenges in the Characterization of Myeloid Neoplasms. Pathobiology. 2024;91(1):5-7.

Monge J, Razavi M, Bao L, Patel SS. Two p53s in a Pod: Co-occurring plasma cell myeloma and therapy-related myeloid neoplasm following lenalidomide therapy. Am J Hematol. 2024;99(2):327-328.

Han Y, Duan X, Yang L, Nilsson-Payant BE, Wang P, Duan F, et al. Author Correction: Identification of SARS-CoV-2 inhibitors using lung and colonic organoids. Nature. 2024;630(8016):E7.